Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Official action

Source. US Consumer Product Safety Commission

Official identifier. 26-157

Date. 2025-12-18

Jurisdiction. United States

Hazard (official). The ointment contains lidocaine, which must be in child-resistant packaging, as required by the https://www.cpsc.gov/Business--Manufacturing/Business-Education/Busines… lang="EN">Poison Prevention Packaging Act. The ointment’s packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

Action / remedy (official). Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.

Product. Mamisan Pain Relieving Topical Ointment

Identification details. This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

Units. About 50,330

Incidents reported by CPSC. None reported

Remedy type. Repair

Sold at. Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.

Official record

Licence: US Government recall data made available for business and application reuse

Attribution: Source: U.S. Consumer Product Safety Commission recall notice